Abstract
High-risk human papillomavirus (HPV) is a major causative agent of cervical cancer and the E6 and E7 genes encode the major HPV oncoproteins. The E7 protein from high-risk HPV types alters cell cycle progression and represses genes encoding components of the antigen-presentation pathway, suggesting a role for E7 in tumour immune evasion. We show that knockdown of E7 expression in HPV16- and HPV18-transformed cervical carcinoma cells by RNA interference increased expression of major histocompatibility complex (MHC) class I at the cell surface and reduced susceptibility of these cells to natural killer (NK) cells. Tetracycline-regulated induction of HPV16 E7 resulted in reduced expression of cell surface MHC class I molecules and increased NK cell killing. Our results suggest that, for HPV-associated malignancies, reduced MHC class I expression is the result of an active immune evasion strategy that has evolved to assist viral replication.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abele R, Tampe R . (2006). Modulation of the antigen transport machinery TAP by friends and enemies. FEBS Lett 580: 1156–1163.
Berger AJ, Baege A, Guillemette T, Deeds J, Meyer R, Disbrow G et al. (2002). Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteins. Am J Pathol 161: 603–610.
Bottley G, Cook GP, Blair GE . (2007). A flow cytometric assay for analysis of natural-killer cell-mediated cytolysis of adenovirus-transformed cells. Methods Mol Med 131: 221–230.
Bottley G, Cook GP, Meade JL, Holt JR, Hoeben RC, Blair GE . (2005). Differential expression of LFA-3, Fas and MHC Class I on Ad5- and Ad12-transformed human cells and their susceptibility to lymphokine-activated killer (LAK) cells. Virology 338: 297–308.
Brady CS, Bartholomew JS, Burt DJ, Duggan-Keen MF, Glenville S, Telford N et al. (2000). Multiple mechanisms underlie HLA dysregulation in cervical cancer. Tissue Antigens 55: 401–411.
Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS et al. (1998). HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391: 795–799.
Cromme FV, Airey J, Heemels MT, Ploegh HL, Keating PJ, Stern PL et al. (1994). Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J Exp Med 179: 335–340.
Cromme FV, Snijders PJ, van den Brule AJ, Kenemans P, Meijer CJ, Walboomers JM . (1993). MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpression. Oncogene 8: 2969–2975.
Garcia-Lora A, Algarra I, Collado A, Garrido F . (2003). Tumour immunology, vaccination and escape strategies. Eur J Immunogenet 30: 177–183.
Georgopoulos NT, Proffitt JL, Blair GE . (2000). Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins. Oncogene 19: 4930–4935.
Hall AH, Alexander KA . (2003). RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J Virol 77: 6066–6069.
Hewitt EW . (2003). The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology 110: 163–169.
Howley PM, Lowy DR . (2007). Papillomaviruses. In: Knipe DM (ed). Fields Virology, 5th edn. Lippincott Williams & Wilkins: USA, pp 2299–2354.
Jackman M, Lindon C, Nigg EA, Pines J . (2003). Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat Cell Biol 5: 143–148.
Jiang M, Milner J . (2002). Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21: 6041–6048.
Kaznelson DW, Bruun S, Monrad A, Gjerlov S, Birk J, Ropke C et al. (2004). Simultaneous human papilloma virus type 16 E7 and cdk inhibitor p21 expression induces apoptosis and cathepsin B activation. Virology 320: 301–312.
Lanier LL . (2005). NK cell recognition. Annu Rev Immunol 23: 225–274.
Lee N, Llano M, Carretero M, Ishitani A, Navarro F, López-Botet M et al. (1998). HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 95: 5199–5204.
Li H, Ou X, Xiong J, Wang T . (2006). HPV16E7 mediates HADC chromatin repression and downregulation of MHC class I genes in HPV16 tumorigenic cells through interaction with an MHC class I promoter. Biochem Biophys Res Comm 349: 1315–1321.
Marin R, Ruiz-Cabello F, Pedrinaci S, Méndez R, Jiménez P, Geraghty DE et al. (2003). Analysis of HLA-E expression in human tumors. Immunogenetics 54: 767–775.
Moretta L, Moretta A . (2004). Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 23: 255–259.
O'Brien PM, Campo MS . (2003). Papillomaviruses: a correlation between immune evasion and oncogenicity? Trends Microbiol 11: 300–305.
Pett MR, Herdman MT, Palmer RD, Yeo GS, Shivji MK, Stanley MA et al. (2006). Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc Natl Acad Sci USA 103: 3822–3827.
Proffitt JL, Sharma E, Blair GE . (1994). Adenovirus 12-mediated down-regulation of the major histocompatibility complex (MHC) class I promoter: identification of a negative regulatory element responsive to Ad12 E1A. Nucleic Acids Res 22: 4779–4788.
Tang S, Tao M, McCoy Jr JP, Zheng ZM . (2006). The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. J Virol 80: 4249–4263.
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12–19.
Zhao B, Ricciardi RP . (2006). E1A is the component of the MHC class I enhancer complex that mediates HDAC chromatin repression in adenovirus-12 tumorigenic cells. Virology 352: 338–344.
Acknowledgements
We thank Dr M Jiang and Professor AJ Milner for advice on siRNA transfection, Dr J Pines for WT8 cells and A Trejdosiewicz and J Jarvis for technical assistance. This research was supported by Yorkshire Cancer Research, the Medical Research Council (UK) and the Danish Research Council for Nature and the Universe.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Rights and permissions
About this article
Cite this article
Bottley, G., Watherston, O., Hiew, YL. et al. High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells. Oncogene 27, 1794–1799 (2008). https://doi.org/10.1038/sj.onc.1210798
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210798
Keywords
This article is cited by
-
HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management
Nature Reviews Clinical Oncology (2022)
-
HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources
Nature Communications (2022)
-
Human Papilloma Virus and Chlamydia trachomatis: Casual Acquaintances or Partners in Crime?
Current Clinical Microbiology Reports (2019)
-
Microparticles produced by human papillomavirus type 16 E7-expressing cells impair antigen presenting cell function and the cytotoxic T cell response
Scientific Reports (2018)
-
Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status
European Archives of Oto-Rhino-Laryngology (2016)